medigraphic.com
ISSN 1405-8790 (Print)

2017, Number 3-4

<< Back

Rev Mex Med Fis Rehab 2017; 29 (3-4)

Use of botulinic toxin type A, as treatment for left hemifacial spasm: report of a case in the Physical Medicine and Rehabilitation Service, Hospital Regional «1° de Octubre»

Pimentel CC, Sánchez OÁO, Mendieta SOE, Amador SVS

Language: Spanish
References: 16
Page: 57-61
PDF size: 256.51 Kb.


ABSTRACT

Hemifacial spasm is a chronic movement disorder characterized by involuntary, irregular, tonic or clonic contractions of the muscles innervated by the homolateral facial nerve. Contractions may persist during sleep and decrease with rest and relaxation. Most cases are idiopathic. The start is between the fourth and fifth decades of life and rarely before age 20. The ratio is 3: 2 in favor of women. There are already many studies that show the effectiveness of botulinum toxin as an effective treatment. It is currently the treatment of choice.


REFERENCES

  1. Wang A, Jankovic J. Hemifacial spasm: clinical findings and treatment. Muscle Nerve. 1998; 21 (12): 1740-1747.

  2. Chaudhry N, Srivastava A, Joshi L. Hemifacial spasm: the past, present and future. J Neurol Sci. 2015; 356 (1-2): 27-31.

  3. Schultze F. Linksseitiger facialiskrampf in folge eines aneurysma der arteria vertebralis sinistra. Arch Pathol Anat. 1875; 65 (3): 385-391.

  4. Bradley EA, Hodge DO, Bartley GB. Benign essential blepharospasm among residents of Olmsted County, Minnesota, 1976 to 1995: an epidemiologic study. Ophthal Plast Reconstr Surg. 2003; 19 (3): 177-181.

  5. Hallett M. Blepharospasm: recent advances. Neurology. 2002; 59 (9): 1306-1312.

  6. Nielsen VK. Electrophysiology of the facial nerve in hemifacial spasm: ectopic/ephaptic excitation. Muscle Nerve. 1985; 8 (7): 545-555.

  7. Girard N, Poncet M, Caces F, Tallon Y, Chays A, Martin-Bouyer P et al. Three-dimensional MRI of hemifacial spasm with surgical correlation. Neuroradiology. 1997; 39 (1): 46-51.

  8. Rosenstengel C, Matthes M, Baldauf J, Fleck S, Schroeder H. Hemifacial spasm: conservative and surgical treatment options. Dtsch Arztebl Int. 2012; 109 (41): 667-673.

  9. Yaltho TC, Jankovic J. The many faces of hemifacial spasm: differential diagnosis of unilateral facial spasms. Mov Disord. 2011; 26 (9): 1582-1592.

  10. Wang A, Jankovic J. Hemifacial spasm: clinical findings and treatment. Muscle Nerve. 1998; 21 (12): 1740-1747.

  11. Colosimo C, Bologna M, Lamberti S, Avanzino L, Marinelli L, Fabbrini G et al. A comparative study of primary and secondary hemifacial spasm. Arch Neurol. 2006; 63 (3): 441-444.

  12. Naraghi R, Tanrikulu L, Troescher-Weber R, Bischoff B, Hecht M, Buchfelder M et al. Classification of neurovascular compression in typical hemifacial spasm: three-dimensional visualization of the facial and the vestibulocochlear nerves. J Neurosurg. 2007; 107 (6): 1154-1163.

  13. Park HL, Lim SM, Kim TH, Kang KH, Kang H, Jung YH
et al. Intractable hemifacial spasm treated by pulsed radiofrequency treatment. Korean J Pain. 2013; 26 (1): 62-64.

  14. Singh S. Botulinum toxin in hemifacial spasm: revisited. Indian J Plast Surg. 2013; 46 (1): 159-160.

  15. Mezaki T. Clinical application of botulinum toxin. Brain Nerve. 2011; 63 (7): 785-794.

  16. Batisti M, Kleinfelder F, Galli NB, Moro A, Munhoz RP, Teive HA. Treatment of hemifacial spasm with botulinum toxin type a: effective, long lasting and well tolerated. Arq Neuropsiquiatr. 2017; 75 (2): 87-91.




2020     |     www.medigraphic.com